title: Are patients with primary hepatocellular carcinoma infectious of hepatitis B, C and D viruses?
abstract: Primary HepatoCellular Carcinoma (PHCC) has been strongly associated with HBV and HCV infections among other aetiological factors. However; do the patients still spread the viruses? This study involved forty one Nigerian adult patients with PHCC and 45 controls who were tested for HBsAg, HBeAg, Anti-HBe, Anti-HBs, anti-HCV IgM and IgG, anti-HDV and HDV antigen using ELISA. Statistical analysis was carried out with the student - t - test and Mc Nemar test at p < 0.05. The subjects consisted of male:female ratio of 3:1 for both the PHCC patients and controls. Evidence of exposure to hepatitis B, C and D viruses was detected in 95.1%, 44% and 0% of the patients respectively while the respective values of 24%, 11.1% and 0% were obtained for the controls. Indication for high (HBeAg) and low (anti HBe) HBV viral replication, and acute HBV infection were detected in 12.5%, 92.7% and 2.2% respectively among the patients while only 35.6% of the controls had low HBV viral replication. Acute and chronic infections of HCV were also found in 26.8% and 24.4% of the patients respectively compared to the respective values of 2.2% and 11.1% of the controls. Occult HBV infection occurred in equal proportions (11%) of both the patients (31.7%) and controls (35.6%). In conclusion, infectious HBV and HCV particles are present among Nigerian patients with PHCC while HDV infection is uncommon. Hence, safe medical care should be practised for all patients with PHCC while relatives should be screened for these viruses.
authors.affiliation: Department of Medicine, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria. soola2001@yahoo.com
authors.forename: S O
authors.initials: SO
authors.lastname: Olal
authors.forename: A
authors.initials: A
authors.lastname: Akere
authors.forename: J A
authors.initials: JA
authors.lastname: Otegbayo
authors.forename: G N
authors.initials: GN
authors.lastname: Odaibo
authors.forename: D O
authors.initials: DO
authors.lastname: Olaleye
authors.forename: N B
authors.initials: NB
authors.lastname: Afolabi
authors.forename: E A
authors.initials: EA
authors.lastname: Bamgboye
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D015897:Comorbidity; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood; D018963:Hepatitis Antigens / Q000097:blood; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology; D003699:Hepatitis D / Q000453:epidemiology / Q000276:immunology; D006518:Hepatitis Viruses / Q000276:immunology*; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009549:Nigeria / Q000453:epidemiology; D012698:Serologic Tests / Q000379:methods
chemical_list: D006508:Hepatitis Antibodies; D018963:Hepatitis Antigens